[Editorial] Statins: new US guideline sparks controversy
Statins reduce cholesterol and are prescribed to many millions of people in high-income countries—not only high-risk patients with familial hypercholesterolaemia, for example, but also for primary prevention of atherosclerotic cardiovascular disease. Adverse events such as statin-induced myopathy are rare, and statins are likely to have contributed to the substantial fall in cardiovascular events, including stroke, at population level in recent decades.
Source: LANCET - Category: Journals (General) Authors: The Lancet Tags: Editorial Source Type: research
More News: Cardiology | Cardiovascular | Cholesterol | General Medicine | Heart | Statin Therapy | Stroke